semaglutide uses Summary of clinical use FDA Approves Oral Semaglutide for
Description
Obesity Drug MariTide Achieves Up to 20 Percent Weight Loss in Phase 2 Trial

PGC: OR = 0.71, 95% CI [0.580.87]

9,10 The mechanism of the relationship is poorly understood, with hypotheses including that a drop in blood sugar can lead to a rise in VEGF expression 11,12 and that systemic glycemic changes can correspond with glucose concentration in the vitreous, and in turn lead to retinal injury

WormBook, pp 119

Calibrate your expectations to the format you are using

These warning signs should trigger immediate caution
